z-logo
open-access-imgOpen Access
Hereditary spastic paraplegia type 8: Neuropathological findings
Author(s) -
Pehrson Caroline,
Hertz Jens Michael,
Wirenfeldt Martin,
Stenager Egon,
Wermuth Lene,
Winther Kristensen Bjarne
Publication year - 2018
Publication title -
brain pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.986
H-Index - 132
eISSN - 1750-3639
pISSN - 1015-6305
DOI - 10.1111/bpa.12494
Subject(s) - hereditary spastic paraplegia , paraplegia , spastic , medicine , neuroscience , pathology , physical medicine and rehabilitation , psychology , biology , spinal cord , genetics , cerebral palsy , psychiatry , phenotype , gene
An interesting report is presented by de Bot et al (2012) (4) on a rare type 8 autosomal-dominant form of hereditary spastic paraplegia (HSP) caused by a mutation in the VCP gene. Here, we present, for the first time we believe, the neuropathological findings in an HSP type 8 (SPG8) case with a confirmed KIAA0196 mutation. HSP is clinically and genetically a heterogeneous group of disorders with more than 72 loci and 55 genes known to be involved so far (12). SPG8 has been described in 13 families (2, 5, 8, 10) and presents as a pure spastic paraplegia without associated neurological abnormalities in all families but one (2). SPG8 is caused by mutations in the strumpellin gene KIAA0196. Eleven different missense mutations (2, 5, 10) and one large deletion in intron 10— exon 15 of KIAA0196 (10) have been identified so far in patients with SPG8 (www.hgmd.cf.ac.uk). Strumpellin knockdown experiments in human neuroblastoma cells demonstrated reduced axonal outgrowth, and knockdown studies in zebrafish revealed severe contractile cardiac dysfunction, tail curvature, and impaired motility, implying a strumpellin loss-of-function pathogenesis of SPG8 (3). The major neuropathological finding in pure HSP is axonal degeneration, maximal in the terminal portions of the longest descending and ascending tracts (1). A case-control study quantifying corticospinal tract axon number showed reduced cross-sectional area and axonal density in the corticospinal tracts with a more pronounced axonal loss in the distal neuraxis in HSP patients. The cross-sectional area and axonal density of the sensory tracts were reduced only in the upper regions of the spinal cord. This is consistent with a “dying back” axonal degeneration (6). The proband presented here is a 46-year-old male with a slowly progressing spastic paraplegia. He was healthy until the age of 37, where he had onset of pain in the lower limbs, intermittent dropfoot, foot clonus, and slight ataxia. At age 45, he had an unaided walking distance of 200 m, spasticity and exaggerated deep tendon reflexes in the lower limbs, foot clonus and slight paresis of the hip corresponding to an estimated Spastic Paraplegia Rating Scale (SPRS) score of 19. He had no symptoms from the bladder, and no cognitive or psychiatric symptoms. MRI of the brain and spinal cord was normal. The proband’s mother was healthy until her first pregnancy at 25 years of age, where she exhibited slight paresis and spasticity of the legs. A neurological examination at age 34 revealed slight eye movement ataxia, ataxia of the legs, and exaggerated patellar and heel tendon reflexes corresponding to an estimated SPRS score of 15. She was suspected of having multiple sclerosis, but the diagnosis was never confirmed. She was re-evaluated at age 42 because of urine incontinence and progression of the spastic paraparesis— signs and symptoms corresponding to an estimated SPRS score of 20. At the age of 61, she suffered from severe depression and complained of cognitive deficits. Her unaided walking distance was 25 m (estimated SPRS score 25). She died 70-year old following a hemicolectomy caused by stage T3 colon cancer. Her medical history also included surgical treatment and radiotherapy for advanced breast cancer, hyperthyroidism, and atrial fibrillation. An autopsy was performed to determine the cause of the patient’s symptoms. Informed consent for performing the autopsy and related analyses as well to publish this article was obtained from the son of the deceased woman. There are no other known affected family members. A 43-yearold brother of the proband has no symptoms of spastic paraplegia. The maternal grandfather died suddenly and unexpectedly 65-year old and the maternal grandmother had unconfirmed Parkinson’s disease and died 89-year old. Mutational analysis of genomic DNA from a peripheral blood sample from the proband revealed a missense mutation in the gene for strumpellin (KIAA0196) in exon 16: c.1876G>T; p.(Val626Phe) previously found to be heterozygously present in a British family and three large North American families with European ancestry thus confirming the clinical diagnosis of SPG8. The presence of the KIAA0196 mutation in the proband’s deceased mother was confirmed on DNA extracted from frozen normal colon tissue. The mutation was absent in DNA extracted from peripheral blood from the proband’s younger brother. The weight of the fixated brain was 1002 grams. The gross external appearance of the brain was normal and there were no signs of atrophy. Sections from the cerebrum, cerebellum, pons, mesencephalon and medulla oblongata appeared normal, without signs of atrophy, which was confirmed by histological examination. The spinal cord was 39-cm long. There was severe atrophy of the spinal cord between the cervical and lumbar enlargements, where the spinal cord consisted mainly of vessels and meninges (Figure 1). Humped surfaces were found corresponding to the cervical enlargement and more widespread above, at, and below the lumbar enlargement. Grey matter was not readily distinguished on gross

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here